Medicare
The rule would increase aggregate payments by approximately $25 million relative to FY 2022.
Sens. Bob Casey, D-Pa., and Chuck Grassley, R-Iowa, last week introduced a Senate companion to the Rural Hospital Support Act.
Medicare will only cover FDA-approved monoclonal antibodies that target amyloid to treat Alzheimer’s disease for beneficiaries enrolled in qualifying clinical trials.
As Congress prepares to adjourn for its April recess, AHA today emphasized to congressional leaders the need for immediate additional support for hospitals and health systems.
Congress in December prohibited implementing the model before January 2023.
The Centers for Medicare & Medicaid Services late yesterday issued a proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2023 that would increase payments by 2.8% ($170 million) relative to FY 2021.
CMS proposes to increase IPF payments by a net 2.7%, equivalent to $50 million, in FY 2023.
At the end of first-quarter fiscal year 2022 Dec. 31, a total of 52,641 appeals remained pending at the Office of Medicare Hearings and Appeals, almost 88% fewer than the 426,594 appeals identified in the 2018 court order.
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA
AHA v Becerra March 2022 Medicare Appeals Dashboard